1. Mackowiak B, Li L, Ziman A, Lynch C, Heyward S, Xia M, and Wang H. Automated imaging analysis identifies mosapride citrate represses gluconeogenesis through activation of the constitutive androstane receptor. Biochem. Pharmacol. 2019, 168: 224-236, PMID: 31306645.
  2. Li L, Li Z, Mackowiak B, Welch M, Heyward S, Swaan PW, and Wang H. Mechanistic insights of phenobarbital-mediated activation of human but not mouse PXR. Mol. Pharmacol. 2019, 96(3): 345-354.
  3. Feng Y, Xie Y, Xu M, Li L, Selcer KW, Oberly PJ, Poloyac SM, Wang H, Li C, Dong F, Yu C, and Xie W. The hepatic steroid sulfatase and its inflammatory regulation dictates the hormone replacement therapy efficacy of conjugated equine estrogens (Premarin®). J Biol Chem. 2019, (Epub ahead of print), PMID: 31217279.
  4. Garzel B, Zhang L, Huang S, and Wang H. A change in flow: looking beyond transporter inhibition in the development of drug-induced cholestasis. Curr Drug Metab. 2019, (Epub ahead of print), PMID: 31288715.
  5. Liang D, Li L, Lynch C, Xia M, Xue F, and Wang H. DL5050, A selective agonist for the human constitutive androstane receptor. ACS Med. Chem. Let. 2019, 10(7): 1039-1044, PMID: 31312405.
  6. Liang D, Li L, Lynch C, Mackowiak B, Ai Y, Yin Y, Xia M, Wang H, and Xue F. Human CAR agonist DL5016: A novel sensitizer for cyclophosphamide-based chemotherapies. Eur. J. Med. Chem. 2019, 179: 84-99, PMID: 31247375.
  7. Lynch C, Mackowiak B, Huang R, Li L, Heyward S, Sakamuru S, Wang H, and Xia M. Identification of modulators that activate the constitutive androstane receptor from the Tox21 10K compound library. Toxicol. Sci. 2019, 167(1): 282-292). PMID: 30247703.
  8. Mackowiak B, Hodge J, Stern S, and Wang H. The roles of xenobiotic receptors: beyond chemical disposition. Drug Metab Dispos. 2018, 46(9): 1361-1371, PMID: 29759961.
  9. Wolfson B, Lo PK, Yao Y, Li L, Wang H, and Zhou Q. Impact of miR-140 deficiency on non-alcoholic fatty liver disease. Mol Nutr Food Res. 2018, 62(13): e1800189, PMID: 29701903.
  10. Zaw MM, Munuhe T, Hedrich WD, Wang H, Banazadeh MH, Gadsden SA, Zhu L, and Ma R. Fabrication of a cell culture plate with a 3D printed mold and thermal analysis of PDMS-based casting process. J of Thermal Sci Eng Appl. 2018, Vol. 10: 061002-1-8.
  11. Yang X, Pan Y, Qiu Z, Du Z, Zhang Y, Fa P, Gorityala S, Ma D, Li S, Wang H, Yan C, Xu Y, Ruth K, Ma Z, and Zhang J. RNF126 as a biomarker of a poor prognosis in invasive breast cancer and CHK1 inhibitor efficacy in breast cancer cells. Clin Cancer Res. 2018, 24(7): 1629-1643. PMID: 29326282.
  12. Hedrich WD, Fandy TE, Wang H, and Hassan HE. Antibody drug conjugates: Changing the chemotherapy Landscape. Clin Pharmacokinet. 2017, 57(6): 687-703. PMID: 29188435.
  13. Li Z, Li D, Choi E, Lapidus R, Raman C, Zhang L, Huang S, Shapiro P, and Wang H. Targeted disruption of SLC13A5 inhibits the proliferation of human hepatocarcinoma cells through disturbing energy metabolism. J. Biol. Chem. 2017, (Editor’s Pick) PMID: 28655760.
  14. Mackowiak B, Li L, Li D, Jones JW, Heyward S, Kane M, Swaan P, and Wang H. Metabolism-based conversion of PK11195 from an antagonist to an agonist of human CAR in liver cells. Mol. Pharmacol. 2017, 92(1): 75-87. PMID: 28442602.
  15. Zuo R, Li F, Sweta P, Cooper KL, Hong Y, Liu J, Faris RA, Li D, and Wang H. Evaluation of a novel renewable hepatic cell model for precition of clinical CYP3A4 induction using correlation based RIS approach. Drug Metab. Dispos. 2017, 45(2): 198-207. PMID: 28062541.
  16. Lynch C, Zhao J, Wang H, and Xia M. Quantitative high-throughput luciferase screening in identifying CAR modulators. Methods Mol. Biol. 2016, 1473: 33-42. PMID: 27518621.
  17. Fahmi OA, Einolf HJ, Ramsden D, Palamanda J, Chen L, Sinz MW, Shebley M, and Wang H. Evaluation of CYP2B6 induction and prediction of clinical DDI: Considerations from the IQ Consortium Induction Working Group. Drug Metab. Dispos. 2016, 44(10): 1720-30. PMID: 27422672.
  18. Hedrich WD, Hassan HE, and Wang H. Insights into CYP2B6-mediated drug-drug interactions. Acta Pharmaceutica Sinica B. 2016, 6(5): 413-425. PMID: 27709010.
  19. Zhang L, Miao X, Wang X, Pan H, Li P, Ren H, Jia Y, Lu C, Wang H, Yuan L, and Zhang G. Antiproliferation of berberine is mediated by epigenetic modification of constitutive androstane receptor metabolic pathway in hepatoma cells. Sci. Rep. 2016, 6:28116. PMID: 27311637.
  20. Jackson JP, Li L, Deibert E, Wang H, and Ferguson SS. Contextualizing hepatocyte functionality of HepaRGTM to sandwich cultures of human hepatocytes & evaluation of CAR translocation in response to phenobarbital. Drug Metab. Dispos. 2016, 44(9): 1463-79. PMID: 27338863.
  21. Li L, Li D, Heyward S, and Wang H. Transcriptional regulation of CYP2B6 by hepatocyte nuclear factor 3β in in human liver cells. Plos One 2016, 11(3):e0150587. PMID: 26930610.
  22. Mackowiak B and Wang H. Mechanisms of xenobiotic receptor activation: direct vs. indirect. BBA-Gene Regulation Mechanisms 2016, 1859(9): 1130-40. PMID: 26877237.
  23. Hedrich WD, Xiao J, Heyward S, Zhang Y, Zhang J, Baer MR, Hassan HE, and Wang H. Activation of the constitutive androstane receptor increases the benefit-risk ratio of CHOP-based treatment of lymphomas. Mol. Cancer Ther. 2016, 15(3): 392-401. PMID: 26823489.
  24. Wang Y, Deng O, Feng Z, Du Z, Xiong X, Lai J, Yang X, Alvarado-Kristensson M, Wang H, Taylor D, Yan C, Chen C, Ma Z, and Zhang J. RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression. Oncogene 2016, 35(11): 1363-72. PMID: 26234677.
  25. Wang A, Yang Z, Grinchuk V, Smith A, Qin B, Lu N, Wang D, Wang H, Ramalingam TR, Wynn TA, Urban JF, Shea-Donohue T, and Zhao A. IL-25 or IL-17E protects against high-fat diet induced hepatic steatosis in mice dependent upon IL-13 activation of STAT6. J. of Immunology, 2015, 195(10): 4771-80. PMID: 26423151.
  26. Li D, Mackowiak B, Mitchell M, Zhang L, Huang S, and Wang H. Genome-wide analysis of human constitutive androstane receptor transcriptome in Wild-type and knockout HepaRG cells. Biochem. Pharmacol. 2015, 98(1): 190-202. PMID: 26275810.
  27. Gharavi R, Hedrich W, Wang H, and Hassan HE. Potential clinical implications of drug transporter interactions with opioids. Pharm. Res. 2015, 32(8): 2477-502. PMID: 25972096.
  28. Lynch C, Zhao J, Huang R, Xiao J, Li L, Heyward S, Xia M, and Wang H. Quantitative high-throughput identification of approved drugs as modulators of human constitutive androstane receptor. Sci. Rep. 2015, 5, 10405; doi: 10.1038/ srep10405. PMID: 25993555.
  29. Li L, Li H, Garzel B, Sueyoshi T, Li Q, Shu Y, Zhang J, Hu B, Heyward S, Moeller T, Xie W, Negishi M, and Wang H. The SLC13A5 gene, encoding the citrate transporter, is a novel transcriptional target of the pregnane X receptor and constitutive androstane receptor, and sensitizes drug-induced steatosis in human liver. Mol. Pharmacol. 2015, 87(4): 674-82. PMID: 25628225.
  30. Yang H, and Wang H. Signaling control of the constitutive androstane receptor. Protein & Cell. 2014, 5(2): 113-123. PMID: 24474196.
  31. Zhuo W, Hu L, Lv J, Wang H, Zhou H, and Fan L. Pharmacogenomics implications of Pregnane X receptor in oncology. Can. Chemother. & Pharmacol. 2014, 74(2): 217-27. PMID: 24889719.
  32. Lynch C, Pan Y, Li L, Heyward S, Moeller T, Swaan P, and Wang H. Activation of human CAR inhibits gluconeogenesis without affecting lipogenesis or fatty acid synthesis. Toxicol. Appl. Pharmacol. 2014, 279(1): 33-42. PMID: 24878338.
  33. Garzel B, Yang H, Lynch C, Zhang L, Huang S, Polli J, and Wang H. The role of BSEP gene repression in drug-induced cholestatic injury. Drug Metab. Dispos. 2014, 42(3): 318-22. PMID: 24335466.
  34. Yang H, Garzel B, Li L, Shapiro P, and Wang H. Metformin represses CAR-mediated CYP2B6 induction through affecting the CAR phosphorylation signaling. Mol. Pharmacol. 2014, 85(2): 249-60. PMID: 24252946. (Selected by Faculty of 1000 Biology)
  35. Sueyoshi T, Li L, Wang H, Moore R, Kodavanti P, Lehmler H, Negishi M, and Birnbaum L. Flame retardant BDE-47 effectively activates nuclear receptor CAR in human primary hepatocytes. Toxicol. Sci. 2014, 137(2): 292-302. PMID: 24218150.
  36. Hassan H, Myers A, Lee I, Mason C, Wang D, Sinz M, Wang H, and Eddington N. Induction of xenobiotic receptor, transporters and drug metabolizing enzymes by oxycodone. Drug Metab. Dispos. 2013, 41(5): 1060-9. PMID: 23439660.
  37. Wang D, Li L, Yang H, Ferguson S, Baer MR, Gartenhaus RB, and Wang H. The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood. 2013, 121(2): 329-38. PMID: 23160467.
  38. Lynch C, Pan Y, Li L, Ferguson S, Xia M, Swaan P, and Wang H. Identification of novel activators of constitutive active/androstane receptor (CAR) from FDA-approved drugs by integrated computational and biological approaches. Pharm. Res. 2013, 30(2): 489-501. PMID: 23090669.
  39. Ou Z, Shi X, Gilroy RK, Kirisci L, Romkes M, Lynch C, Wang H, Xu M, Jiang M, Ren S, Gramignoli R, Strom SC, Huang M, and Xie W. Regulation of the human hydroxysteroid sulfotransferase SULT2A1 by RORα and RORγ and its potential relevance in human liver diseases. Mol. Endocrinol. 2013, 27(1): 106-15. PMID: 23211525.
  40. Li L, Sinz M, Zimmermann K, and Wang H. An IGF-1R inhibitor induces CYP3A4 expression through a PXR-independent, non-canonical CAR-related mechanism. J. Pharmacol. Exp. Ther. 2012, 340(3): 688-97. PMID: 22171088
  41. Wang D, and Wang H. Oxazaphosphorine bioactivation and detoxification: the role of xenobiotic receptors. Acta Pharmaceutica Sinica B. 2012, 2(2): 105-115.
  42. Li Q, Peng X, Yang H, Wang H, and Shu Y. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice. Mol. Pharm. 2011, 8(6): 2476-83. PMID: 21991918.
  43. Wang D, Li L, Fuhrman J, Ferguson S, and Wang H. The role of CAR in oxazaphosphorine-mediated induction of DMEs in human hepatocytes. Pharm. Res. 2011, 28(8): 2034-44. PMID: 21487929.
  44. Pan Y, Li L, Ekins S, Kim G, Wang H, and Swaan P. Identification of novel hPXR activators amongst prescribed drugs by integrated structure- and ligand-based virtual screening. Drug Metab. Dispos. 2011, 39(2): 337-44. PMID: 21068194.
  45. Li L, Hassan H, Tolson A, Ferguson S, Eddington NE, and Wang H. Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. J. Pharmacol. Exp. Ther. 2010, 335(3): 562-71. PMID: 20829393.
  46. Tompkins L, Li H, Li L, Lynch C, Xie Y, Nakanishi T, Ross DD, and Wang H. A novel xenobiotic responsive element regulated by AhR is involved in the induction of BCRP/ABCG2 in LS174T cells. Biochem. Pharmacol. 2010, 80(11): 1754-61. PMID: 20804740.
  47. Li H, Ferguson S, and Wang H. Novel mechanisms for synergistic CYP2B6 induction between a polymorphic mutation in CYP2B6 promoter and PXR activation. Mol. Pharmacol. 2010, 78(4): 704-13. PMID: 20624854.
  48. Tompkins L, Lynch C, Haidar S, Polli J, and Wang H. Effects of commonly used excipients on the expression of CYP3A4 in colon and liver cells. Pharm. Res. 2010, 27(8): 1703-12. PMID: 20503067.
  49. Tolson A, and Wang H. Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv. Drug Deliv. Rev. 2010, 62(13): 1238-49. PMID: 20727377.
  50. Li H, and Wang H. Activation of xenobiotic receptors: driving into the nucleus. Expert Opin. Drug Metab. Toxicol. 2010, 6(4): 1-18. PMID: 20113149.
  51. Chen T, Tompkins L, Li L, Li H, Zheng Y, and Wang H. A single amino acid controls the functional switch of human CAR1 to the xenobiotic sensitive splicing variant CAR3. J. Pharmacol. Exp. Ther. 2010, 332(1): 106-115. PMID: 19820207.
  52. Tolson AH, Li H, Eddington ND, and Wang H. Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor. Drug Metab. Dispos. 2009, 37(9): 1887-1894. PMID: 19520773.
  53. Li H, Chen T, Cottrell J, and Wang H. Nuclear translocation of Ad-hCAR: a novel tool for screening of human CAR activators in human primary hepatocyte cultures. Drug Metab. Dispos. 2009, 37(5): 1098-1106. (cover story) PMID: 19196842.
  54. Li L, Stanton JD, Tolson AH, Luo Y, and Wang H. Bioactive terpenoids and flavonoids from ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through PXR, CAR, and AhR-mediated pathways. Pharm. Res. 2009, 26(4): 872-82. PMID: 19034627.
  55. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M and Wang H. The Peripheral Benzodiazepine Receptor Ligand PK11195 is a Novel Antagonist of Human Constitutive Androstane Receptor. Mol. Pharmacol. 2008, 74(2): 443-453. PMID: 18492798.
  56. Wang H, and Tompkins LM. CYP2B6: New insights into a historically overlooked cytochrome P450 isozyme. Current Drug Metabolism 2008, 9(7): 598-610. PMID: 18781911.
  57. Faucette SR, Zhang TC, Moore R, Sueyoshi T, Omiecinski C, LeCluyse EL, Negishi M, and Wang H. Relative Activation of Human Pregnane X Receptor versus Constitutive Androstane Receptor Defines Distinct Classes of CYP2B6 and CYP3A4 Inducers. J. Pharmacol. Exp. Ther. 2007, 320 (1): 72-80. PMID: 17041008.
  58. Faucette SR, Sueyoshi T, Smith C, Negishi M, LeCluyse EL, and Wang H. Differential regulation of hepatic CYP2B6 and CYP3A4 genes by constitutive androstane receptor but not pregnane X receptor. J. Pharmacol. Exp. Ther. 2006, 317(3): 1200-9. PMID: 16513849.
  59. Noble SM, Carnahan VE, Moore LB, Luntz T, Wang H, Ittoop OR, Stimmel JB, Davis-Searles PR, Watkins RE, Wisely GB, LeCluyse EL, Tripathy A, McDonnell DP, and Redinbo MR. Human PXR forms a trytophan Zipper-mediated Homodimer. Biochemistry. 2006, 45(28): 8579-8589. PMID: 16834332
  60. Smith C, Graham RA, Krol WL, Silver IS, Negishi M, Wang H, and LeCluyse EL. Differential UGT1A1 induction by chrysin in primary human hepatocytes and HepG2 cells. J. Pharmacol. Exp. Ther. 2005, 315:1256-1264. PMID: 16135700
  61. Smith C, Faucette SR, Wang H, and LeCluyse EL. Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers. J. Biochem. & Mol. Tox. 2005, 19 (2): 96-108. PMID: 15849716
  62. Hempel N, Wang H, LeCluyse EL, McManus ME, and Negishi M. The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA Binding Protein (GABP). Mol. Pharmacol. 2004, 66 (6): 1690-701. PMID: 15383623
  63. Wang H, Faucette SR, Moore R, Sueyoshi T, Negishi M, and LeCluyse EL. Human CAR mediates induction of CYP2B6 gene expression by phenytoin. J. Biol. Chem. 2004, 279 (28): 29295-29301. PMID: 15123723.
  64. Faucette, SR, Wang H, Hamilton G, Gilbert D, Jolley S, Lindley C, and LeCluyse EL. Regulation of CYP2B6 expression in primary human hepatocytes by prototypical inducers. Drug Metab. Dispos. 2004, 32 (3): 348-358. PMID: 14977870
  65. Wang H, Faucette SR, Sueyoshi T, Moore R, Ferguson S, Negishi M, and LeCluyse EL. A novel distal enhancer module regulated by PXR/CAR is essential for the maximal induction of CYP2B6 gene expression. J. Biol. Chem. 2003, 278 (16): 14146-52. PMID: 12571232.
  66. Wang H, and Negishi M. Transcriptional regulation of cytochrome P450 2B genes by nuclear receptors. Current Drug Metabolism 2003, 4 (6): 515-25. PMID: 14683479. PMID: 14683479.
  67. Wang H, and LeCluyse EL. The role of orphan nuclear receptors on the regulation of drug metabolism enzymes. Clinical Pharmacokinetics 2003, 42 (15): 1331-1357. 14674787. PMID: 14674787.
  68. Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M, and LeCluyse EL. Glucocorticoids enhance PXR regulated CYP2B6 expression in primary human hepatocytes. Drug Metab. Dispos. 2003, 31 (5): 620-30. PMID: 12695351.
  69. Sahi J, Milad MA, Zheng X, Rose KA, Wang H, Stilgenbauer L, Gilbert D, Jolley S, Stern RH, and LeCluyse EL. Avasimibe induces CYP3A4 and MDR1 gene expression through activation of the pregnane X receptor. J. Pharmacol. Exp. Ther. 2003, 306: 1027-1034. PMID: 12766253.
  70. Chanas B, Wang H, Ghanayem BI. Gender differences in the metabolism of acrylonitrile to cyanide in mice: Role of cytochrome P450 2E1 and epoxide hydrolase. Toxicol. Appl. Pharmacol. 2003, 193(2): 293-302. PMID: 14644629
  71. Wang H, Chanas B, and Ghanayem BI. Cytochrome P450 2E1 (CYP2E1) is the only enzyme responsible for acrylonitrile metabolism to cyanide: comparative studies using CYP2E1-null and wild-type mice. Drug Metab. Dispos. 2002, 30: 911-917. PMID: 12124309.
  72. Wang H, Chanas B, and Ghanayem BI. Effect of methacrylonitrile on cytochrome P-450 2E1 (CYP2E1) expression in male F344 rats. J. Toxicol. Env. Health (Part A) 2002, 65: 523-537. PMID: 11939710.
  73. Lindley C, Hamilton G, Mccune JS, Faucette SR, Shord SS, Hawke RL, Wang H, and LeCluyse EL. The effect of cyclophosphamide with and without dexamethasone on CYP3A4 and 2B6 in human hepatocytes. Drug Metab. Dispos. 2002, 30: 814-821. PMID: 12065440.
  74. Ghanayem BI, Wang H, and Sumner S. Using cytochrome P-450 gene knock-out mice to study chemical metabolism, toxicity, and carcinogenicity. Toxicol. Pathol. 2000, 28(6): 839-850. PMID: 11127301